Natera, Inc.
- NTRA
- NASDAQ
- Medical - Diagnostics & Research
- Genetic Diagnostics
- Non-Invasive Prenatal Testing
$393.44
Today −2.80%Quote Oct 16, 2026, 08:00 PM UTC
+7.41%over the last month
Max drawdown −8.2%From 1-month high −7.6%3 months +49.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$56.71B
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$364.40
−7.4% from here
Floor
$374.93
4.7% below price
Where the price sits
28 analysts
Analyst range, low to high
$245.00$475.00
- Price $393.44
- Resistance $405.02–$409.10
- Consensus $364.40
The price is right under resistance. Analysts' average target sits about 7% lower. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NTRAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Medical - Diagnostics & Research
Employees
6,138
Founded
2003